The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
 
Andrea P. Myers
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Virginia L. Filiaci
No Relationships to Disclose
 
Yuping Zhang
No Relationships to Disclose
 
Michael Pearl
No Relationships to Disclose
 
Kian Behbakht
No Relationships to Disclose
 
Vicky Makker
No Relationships to Disclose
 
Parviz Hanjani
No Relationships to Disclose
 
Susan Zweizig
No Relationships to Disclose
 
James J Burke
Employment - Allergan (I)
Stock and Other Ownership Interests - Allergan (I)
Speakers' Bureau - Janssen
Research Funding - Boehringer Ingelheim; Janssen; Morphotek; Prima BioMed
 
Gordon Downey
No Relationships to Disclose
 
Kimberly K. Leslie
No Relationships to Disclose
 
Michael J. Birrer
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
 
Gini F. Fleming
Research Funding - Corcept Therapeutics (Inst)
Other Relationship - Aeterna Zentaris